CT: Clinical Trials

17 trials of CT, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

17 completed. 17 Phase 1, 3 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 117Completed 17
Phase 23Completed 3

Follow CT: new trials by email Literature Review of CT trials Research Report on CT

Trials (filtered) newest first · largest first

All 17 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Siltuximab for the Prevention of CAR T Cell Related Cytokine Release Syndrome in Patients With CD19 Positive Non-Hodgkin Lymphoma
Biospecimen Collection, Computed Tomography, Positron Emission Tomography - Non-Hodgkin Lymphoma
Phase 1CompletedTimothy Voorhees112023-01-312025-01-31
NKTR-255 in Combination With CAR-T Cell Therapy for the Treatment of Relapsed or Refractory Large B-cell Lymphoma
Cyclophosphamide, Fludarabine, Lisocabtagene Maraleucel - Recurrent Diffuse Large B-Cell Lymphoma, Recurrent Diffuse Large B-Cell Lymphoma, Not Otherwise Specified
Phase 1CompletedFred Hutchinson Cancer Center272022-12-082026-09-21
Fluciclovine and PSMA PET/CT for the Classification and Improved Staging of Invasive Lobular Breast Cancer
Computed Tomography, Fluciclovine F18, Gallium Ga 68 Gozetotide - Anatomic Stage IV Breast Cancer AJCC v8, Invasive Breast Lobular Carcinoma
Phase 1CompletedEmory University202021-07-162025-01-17
Testing the Safety of Adding Either Monalizumab (IPH2201) or Oleclumab (MEDI9447) to Durvalumab (MEDI4736) Plus Standard Radiation Therapy for Locally Advanced Non-small Cell Lung Cancer (NSCLC), ARCHON-1 Trial
Accelerated Hypofractionated Radiation Therapy, Biospecimen Collection, Computed Tomography - Locally Advanced Lung Non-Small Cell Carcinoma, Locally Recurrent Lung Non-Small Cell Carcinoma
Phase 1CompletedNational Cancer Institute (NCI)262019-10-282025-09-23
Gallium Ga 68-DOTATATE PET/CT in Predicting Tumor Growth in Patients With Meningiomas
Computed Tomography, Gallium Ga 68-DOTATATE, Positron Emission Tomography - Meningioma
Phase 1CompletedM.D. Anderson Cancer Center132019-01-102023-09-01
Durvalumab and Vicineum in Subjects With High-Grade Non-Muscle-Invasive Bladder Cancer Previously Treated With Bacillus Calmette-Guerin (BCG)
Durvalumab, Vicineum, Acetaminophen - Urinary Bladder Neoplasms
Phase 1CompletedNational Cancer Institute (NCI)152018-06-072026-10-27
Highly Conformal, Hypofractionated, Focally Dose Escalated Post-Prostatectomy Radiotherapy
Prostate bed with integrated boost, Prostate bed irradiation only, Whole Body Bone Scan - Cancer Of Prostate, Prostate Neoplasms
Phase 1CompletedNational Cancer Institute (NCI)302018-01-172026-08-28
Vaccine Therapy in Treating Patients with Malignant Peripheral Nerve Sheath Tumor That is Recurrent or Cannot Be Removed by Surgery
Computed Tomography, Laboratory Biomarker Analysis, Oncolytic Measles Virus Encoding Thyroidal Sodium Iodide Symporter - Metastatic Malignant Peripheral Nerve Sheath Tumor, Neurofibromatosis Type 1
Phase 1CompletedMayo Clinic92017-03-222024-09-27
Pembrolizumab, Combination Chemotherapy, and Radiation Therapy Before Surgery in Treating Adult Patients With Locally Advanced Gastroesophageal Junction or Gastric Cardia Cancer That Can Be Removed by Surgery
Carboplatin, Computed Tomography, Fluorouracil - Gastric Cardia Adenocarcinoma, Gastroesophageal Junction Adenocarcinoma
Phase 1 / Phase 2CompletedMayo Clinic312016-06-242025-06-22
Testing the Addition of an Experimental Medication MK-3475 (Pembrolizumab) to Usual Anti-Retroviral Medications in Patients With HIV and Cancer
Antiretroviral Therapy, Biopsy, Biospecimen Collection - AIDS-Related Non-Hodgkin Lymphoma, Clinical Stage III Cutaneous Melanoma AJCC v8
Phase 1CompletedNational Cancer Institute (NCI)582016-04-042024-08-09
18F-FDG Uptake Measurements in Malignant Solid Tumors on PET/CT and PET/MR
Fludeoxyglucose F 18, Positron Emission Tomography, Computerized Tomography - Solid Tumor, Adult
Phase 1CompletedWashington University School of Medicine192016-03-012019-04-05
68Ga-PSMA PET/CT or PET/MRI in Evaluating Patients With Recurrent Prostate Cancer
Computed Tomography, Gallium Ga 68-labeled PSMA Ligand Glu-urea-Lys(Ahx), Magnetic Resonance Imaging - Recurrent Prostate Carcinoma
Phase 1 / Phase 2CompletedStanford University102015-06-012018-03-20
Uprosertib, Dabrafenib, and Trametinib in Treating Patients With Stage IIIC-IV Cancer
Biopsy, Biospecimen Collection, Computed Tomography - Hematopoietic and Lymphoid Cell Neoplasm, Locally Advanced Malignant Solid Neoplasm
Phase 1 / Phase 2CompletedNational Cancer Institute (NCI)272013-10-082025-01-14
Imaging Study Compare 4DCT Image
4D CT scans - Esophagus Cancer, Lung Cancer
Phase 1CompletedM.D. Anderson Cancer Center522012-07-012015-11-18
Imaging Antidepressant vs. Cognitive Behavior Therapy Effects on Unipolar Depression
SSRI, CBT - Major Depressive Disorder
Phase 1CompletedUniversity of Pittsburgh982008-06-012019-01-28
Sunitinib Malate in Treating Patients With Unresectable or Metastatic Kidney Cancer or Other Advanced Solid Tumors
Computed Tomography, Fluorothymidine F-18, Laboratory Biomarker Analysis - Adult Solid Neoplasm, Clear Cell Renal Cell Carcinoma
Phase 1CompletedNational Cancer Institute (NCI)252007-05-222017-10-10
Minimum Dose CT Post Lung Biopsy
CT - Lung Cancer
Phase 1CompletedUniversity Health Network, Toronto1002004-01-012007-04-23

Conditions studied

Lung Neoplasms (4)  ·  Lymphoma, Non-Hodgkin (2)  ·  Melanoma (2)  ·  Neoplasm Metastasis (2)  ·  Prostatic Neoplasms (2)  ·  Carcinoma in Situ (1)  ·  Carcinoma, Hepatocellular (1)  ·  Carcinoma, Lobular (1)  ·  Carcinoma, Non-Small-Cell Lung (1)  ·  Carcinoma, Renal Cell (1)  ·  Depression (1)  ·  Depressive Disorder, Major (1)  ·  Esophageal Neoplasms (1)  ·  HIV Infections (1)  ·  Hematologic Neoplasms (1)

Sponsors

National Cancer Institute (NCI) (6)  ·  M.D. Anderson Cancer Center (2)  ·  Mayo Clinic (2)  ·  Emory University (1)  ·  Fred Hutchinson Cancer Center (1)  ·  Stanford University (1)  ·  Timothy Voorhees (1)  ·  University Health Network, Toronto (1)  ·  University of Pittsburgh (1)  ·  Washington University School of Medicine (1)

Countries

United States (16)  ·  Canada (1)

Top investigators

Alexandre Hirayama (1)  ·  Andrei Iagaru (1)  ·  Antoni Ribas (1)  ·  David M Schuster, MD (1)  ·  Deborah E Citrin, M.D. (1)  ·  Dusica Babovic-Vuksanovic, MD (1)  ·  Glenn Liu (1)  ·  Greg J Siegle, PhD (1)  ·  Harry H. Yoon, M.D. (1)  ·  Jason M Johnson (1)  ·  Kathryn Lurain (1)  ·  Narinder Paul, FRCP C (1)  ·  Raju Chelluri, M.D. (1)  ·  Richard L Wahl, M.D. (1)  ·  Steven H Lin (1)

Results publications

PMID 16585452, PMID 22945620, PMID 24643964, PMID 26659347, PMID 31154457, PMID 33641042, PMID 35080914, PMID 38261444, PMID 38976035, PMID 39356983, PMID 41680482

NIH funding

P30CA014520 (1), P30CA015704 (1), P30CA124435 (1), P30CA138292 (1), R01MH074807 (1), U01CA062491 (1), U01CA154967 (1), U10CA032102 (1), U10CA180830 (1), U10CA180868 (1), U10CA180888 (1)